S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(0.07%) $0.927
USD/NOK
(0.35%) $10.88
USD/GBP
(0.07%) $0.793
USD/RUB
(-0.32%) $92.28

Realtime updates for Hangzhou Tigermed [3347.HK]

Exchange: HKSE Sector: Healthcare Industry: Diagnostics & Research
Last Updated28 Mar 2024 @ 04:08

1.89% HKD 29.60

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 04:08):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Hangzhou Tigermed Consulting Co., Ltd. provides contract research organization services in the People's Republic of China and internationally. It operates in Clinical Trial Solutions, and Clinical-related and Laboratory Services segments...

Stats
Today's Volume 1.71M
Average Volume 2.21M
Market Cap 38.02B
EPS HKD0.562 ( 2023-09-30 )
Last Dividend HKD0.616 ( 2023-05-25 )
Next Dividend HKD0 ( N/A )
P/E 10.39
ATR14 HKD0.0500 (0.17%)

Volume Correlation

Long: -0.02 (neutral)
Short: -0.13 (neutral)
Signal:(46.424) Neutral

Hangzhou Tigermed Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Hangzhou Tigermed Correlation - Currency/Commodity

The country flag 0.03
( neutral )
The country flag 0.67
( moderate )
The country flag 0.00
( neutral )
The country flag 0.57
( weak )
The country flag 0.25
( neutral )
The country flag 0.26
( neutral )

Hangzhou Tigermed Financials

Annual 2022
Revenue: HKD7.09B
Gross Profit: HKD2.81B (39.64 %)
EPS: HKD2.32
Q3 2023
Revenue: HKD1.94B
Gross Profit: HKD798.47M (41.17 %)
EPS: HKD0.560
Q2 2023
Revenue: HKD1.91B
Gross Profit: HKD765.56M (40.16 %)
EPS: HKD0.950
Q1 2023
Revenue: HKD1.80B
Gross Profit: HKD715.52M (39.65 %)
EPS: HKD0.660

Financial Reports:

No articles found.

Hangzhou Tigermed Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0.616
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)

Hangzhou Tigermed Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 6.22 - Stable (24.47%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend HKD0.362 2021-05-25
Last Dividend HKD0.616 2023-05-25
Next Dividend HKD0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 3 --
Total Paid Out HKD1.557 --
Avg. Dividend % Per Year 0.00% --
Score 2.98 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 6.22
Div. Directional Score 8.16 --
Next Divdend (Est)
(2024-04-01)
HKD0.652 Estimate 3.13 %
Dividend Stability
0.25 Very Poor
Dividend Score
2.98
Pay Frequency
Annually
Yearly Payout
Year Amount Yield

Warning: Undefined variable $stockPricesArray in /home/getagraph/public_html/stock.php on line 1111

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for HKSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
2886.HK Ex Dividend Junior 2023-05-19 Annually 0 0.00%
1522.HK Ex Dividend Junior 2023-06-29 Sporadic 0 0.00%
0576.HK Ex Dividend Knight 2023-05-08 Annually 0 0.00%
8062.HK Ex Dividend Knight 2023-08-17 Annually 0 0.00%
2018.HK Ex Dividend Knight 2023-05-29 Annually 0 0.00%
1100.HK Ex Dividend Knight 2023-09-14 Semi-Annually 0 0.00%
0179.HK Ex Dividend Knight 2023-07-18 Annually 0 0.00%
3692.HK Ex Dividend Knight 2023-09-15 Semi-Annually 0 0.00%
1668.HK No Dividend Player 2023-09-26 Annually 0 0.00%
0719.HK Ex Dividend Knight 2023-07-07 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.3111.5003.775.66[0 - 0.5]
returnOnAssetsTTM0.07591.2007.478.97[0 - 0.3]
returnOnEquityTTM0.1121.5009.8710.00[0.1 - 1]
payoutRatioTTM0.260-1.0007.40-7.40[0 - 1]
currentRatioTTM2.680.8001.5811.265[1 - 3]
quickRatioTTM2.670.80010.008.00[0.8 - 2.5]
cashRatioTTM1.7361.5001.4662.20[0.2 - 2]
debtRatioTTM0.123-1.5007.96-10.00[0 - 0.6]
interestCoverageTTM29.131.0000.3220.322[3 - 30]
operatingCashFlowPerShareTTM1.8512.009.3810.00[0 - 30]
freeCashFlowPerShareTTM1.4632.009.2710.00[0 - 20]
debtEquityRatioTTM0.175-1.5009.30-10.00[0 - 2.5]
grossProfitMarginTTM0.3981.0006.706.70[0.2 - 0.8]
operatingProfitMarginTTM0.3951.0004.114.11[0.1 - 0.6]
cashFlowToDebtRatioTTM0.4381.0008.688.68[0.2 - 2]
assetTurnoverTTM0.2440.800-1.708-1.367[0.5 - 2]
Total Score10.09

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM10.451.0009.050[1 - 100]
returnOnEquityTTM0.1122.509.9110.00[0.1 - 1.5]
freeCashFlowPerShareTTM1.4632.009.5110.00[0 - 30]
dividendYielPercentageTTM2.251.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM1.8512.009.3810.00[0 - 30]
payoutRatioTTM0.2601.5007.40-7.40[0 - 1]
pegRatioTTM0.1201.500-2.540[0.5 - 2]
operatingCashFlowSalesRatioTTM0.2201.0006.990[0.1 - 0.5]
Total Score6.22

Hangzhou Tigermed

Hangzhou Tigermed Consulting Co., Ltd. provides contract research organization services in the People's Republic of China and internationally. It operates in Clinical Trial Solutions, and Clinical-related and Laboratory Services segments. The company offers regulatory submission and approval, medical translation, and good manufacturing practice (GMP) consulting services; and clinical services in the areas of medical science, early clinical and late phase development, medical monitoring, project management, patient recruitment, and quality management system. It also provides biometrics services comprising data management, biostatistics, and statistical programming; and integrated technology services, such as site management, pharmacovigilance, third party audit and training, medical imaging, clinical trial system solution, central laboratory, pre-clinical, and research hospital. Further, the company offers medical device/ in vitro diagnostics (IVD) services comprising medical device testing, regulatory submission, clinical evaluation and trials, GMP certificate, EU MDR and IVDR preparation, and value-added services; and post-marketing study, real world evidence, and vaccine clinical trial services. Hangzhou Tigermed Consulting Co., Ltd. was incorporated in 2004 and is headquartered in Hangzhou, the People's Republic of China.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators